IL239921A0 - Compositions and methods for treating severe pain - Google Patents
Compositions and methods for treating severe painInfo
- Publication number
- IL239921A0 IL239921A0 IL239921A IL23992115A IL239921A0 IL 239921 A0 IL239921 A0 IL 239921A0 IL 239921 A IL239921 A IL 239921A IL 23992115 A IL23992115 A IL 23992115A IL 239921 A0 IL239921 A0 IL 239921A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- severe pain
- treating severe
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361752356P | 2013-01-14 | 2013-01-14 | |
| PCT/EP2014/050628 WO2014108569A1 (en) | 2013-01-14 | 2014-01-14 | Compositions and methods for treating severe pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL239921A0 true IL239921A0 (en) | 2015-08-31 |
Family
ID=50064547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL239921A IL239921A0 (en) | 2013-01-14 | 2015-07-14 | Compositions and methods for treating severe pain |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2943183A1 (en) |
| JP (1) | JP6474732B2 (en) |
| KR (1) | KR20150129665A (en) |
| CN (1) | CN104968330A (en) |
| AU (1) | AU2014204739B2 (en) |
| BR (1) | BR112015015864B1 (en) |
| CA (1) | CA2897874A1 (en) |
| HK (1) | HK1217650A1 (en) |
| IL (1) | IL239921A0 (en) |
| MX (1) | MX2015009045A (en) |
| RU (1) | RU2677346C2 (en) |
| SG (1) | SG11201505245XA (en) |
| WO (1) | WO2014108569A1 (en) |
| ZA (1) | ZA201505005B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US11896037B2 (en) * | 2016-08-03 | 2024-02-13 | Temple University-Of The Commonwealth System Of Higher Education | Microencapsulation of active agents |
| JP7027786B2 (en) * | 2017-10-12 | 2022-03-02 | ライオン株式会社 | Oral treatment for myofascial pain |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5143934A (en) * | 1990-11-21 | 1992-09-01 | A/S Dumex (Dumex Ltd.) | Method and composition for controlled delivery of biologically active agents |
| GB9613858D0 (en) * | 1996-07-02 | 1996-09-04 | Cortecs Ltd | Hydrophobic preparations |
| SI0989851T1 (en) * | 1997-07-29 | 2003-04-30 | Pharmacia & Upjohn Company | Self-emulsifying formulation for acidic lipophilic compounds |
| CA2294031E (en) * | 1997-07-29 | 2012-04-03 | Pharmacia & Upjohn Company | Self-emulsifying formulation for lipophilic compounds |
| GB2331458B (en) * | 1997-11-21 | 2002-07-31 | Gursharan Singh Moonga | Solubilising systems for difficult pharmaceutical actives for preparing concentrated stable solutions for encapsulation into soft gelatine |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US6267985B1 (en) | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| TR200103188T2 (en) * | 1999-05-07 | 2002-04-22 | Pharmasol Gmbh | Lipid particles based on liquid and solid lipid mixtures. |
| US8663692B1 (en) * | 1999-05-07 | 2014-03-04 | Pharmasol Gmbh | Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
| JP4790950B2 (en) * | 1999-06-14 | 2011-10-12 | コスモ・テクノロジーズ・リミテッド | Controlled release and taste-masked oral pharmaceutical composition |
| US6455067B1 (en) * | 2000-05-24 | 2002-09-24 | Sang-A Pharmaceutical Co., Ltd. | Transdermal patch for nonsteroidal antiinflammatory drug(s) |
| JP2002284705A (en) * | 2001-01-19 | 2002-10-03 | Shiseido Co Ltd | Torpent |
| GB0402679D0 (en) * | 2004-02-06 | 2004-03-10 | Novartis Ag | Organic compounds |
| KR20070084531A (en) * | 2004-11-24 | 2007-08-24 | 머크 앤드 캄파니 인코포레이티드 | Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |
| AU2006240551A1 (en) * | 2005-04-28 | 2006-11-02 | Dsm Ip Assets B.V. | Pharmaceutical dosage forms comprising a lipid phase |
| GB0610867D0 (en) * | 2006-06-01 | 2006-07-12 | Syntaxin Ltd | Treatment of pain |
| GB0704846D0 (en) * | 2007-03-13 | 2007-04-18 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
| ES2423793T3 (en) | 2008-05-26 | 2013-09-24 | Genfit | PPAR agonist compounds, preparation and uses for the treatment of diabetes and / or dyslipidemias |
| CN102048680B (en) * | 2009-11-11 | 2013-05-01 | 河北奥星集团药业有限公司 | Enteric sustained-release preparation containing zaltoprofen and preparation method thereof |
| AU2012213218C1 (en) * | 2011-02-04 | 2017-04-20 | Infirst Healthcare Limited | Compostions and methods for treating chronic inflammation and inflammatory diseases |
| CN102579350B (en) * | 2012-03-02 | 2013-04-24 | 海南灵康制药有限公司 | Pidotimod liposome solid preparation |
-
2014
- 2014-01-14 CA CA2897874A patent/CA2897874A1/en not_active Abandoned
- 2014-01-14 JP JP2015552092A patent/JP6474732B2/en active Active
- 2014-01-14 WO PCT/EP2014/050628 patent/WO2014108569A1/en active Application Filing
- 2014-01-14 KR KR1020157020599A patent/KR20150129665A/en not_active Application Discontinuation
- 2014-01-14 MX MX2015009045A patent/MX2015009045A/en unknown
- 2014-01-14 RU RU2015134136A patent/RU2677346C2/en active IP Right Revival
- 2014-01-14 AU AU2014204739A patent/AU2014204739B2/en active Active
- 2014-01-14 CN CN201480006249.1A patent/CN104968330A/en active Pending
- 2014-01-14 BR BR112015015864-1A patent/BR112015015864B1/en active IP Right Grant
- 2014-01-14 SG SG11201505245XA patent/SG11201505245XA/en unknown
- 2014-01-14 EP EP14702759.3A patent/EP2943183A1/en not_active Withdrawn
-
2015
- 2015-07-13 ZA ZA2015/05005A patent/ZA201505005B/en unknown
- 2015-07-14 IL IL239921A patent/IL239921A0/en unknown
-
2016
- 2016-05-18 HK HK16105731.5A patent/HK1217650A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201505245XA (en) | 2015-08-28 |
| BR112015015864B1 (en) | 2022-08-23 |
| MX2015009045A (en) | 2015-12-17 |
| EP2943183A1 (en) | 2015-11-18 |
| RU2015134136A (en) | 2017-02-20 |
| HK1217650A1 (en) | 2017-01-20 |
| RU2677346C2 (en) | 2019-01-16 |
| AU2014204739A1 (en) | 2015-07-16 |
| CA2897874A1 (en) | 2014-07-17 |
| CN104968330A (en) | 2015-10-07 |
| JP2016504401A (en) | 2016-02-12 |
| BR112015015864A2 (en) | 2017-07-11 |
| AU2014204739B2 (en) | 2016-08-11 |
| ZA201505005B (en) | 2016-10-26 |
| WO2014108569A1 (en) | 2014-07-17 |
| KR20150129665A (en) | 2015-11-20 |
| BR112015015864A8 (en) | 2018-01-16 |
| JP6474732B2 (en) | 2019-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1225305A1 (en) | Methods and compositions for treating brain diseases | |
| IL245281A0 (en) | Methods and compositions for treating cancer | |
| IL273090B (en) | Methods and compositions for the treatment of cancer | |
| EP3035910A4 (en) | Compositions and methods for treating hair | |
| ZA201505390B (en) | Compositions and methods for treating pests | |
| HK1217650A1 (en) | Compositions and methods for treating severe pain | |
| EP2950884A4 (en) | Compositions and methods for treating surface wounds | |
| HK1225647A1 (en) | Compositions and methods for treating cancers | |
| EP3019151A4 (en) | Compositions and methods for treating hair | |
| HK1208598A1 (en) | Methods and compositions for treating pain | |
| SG11201510300RA (en) | Compositions and methods for treating skin | |
| EP3021830A4 (en) | Compositions and methods for treating hair | |
| HK1220374A1 (en) | Compositions and methods for the treatment of carboxyhemoglobinemia | |
| HK1213523A1 (en) | Compositions and methods for treating damaged hair | |
| IL243022B (en) | Compositions and methods for post-harvest treatment | |
| EP2968505A4 (en) | Compositions and methods for treating autoimmune diseases | |
| EP3019150A4 (en) | Compositions and methods for treating hair | |
| HK1222323A1 (en) | Compositions and methods for treating conditions that affect epidermis | |
| EP2971044A4 (en) | Compositions and methods for treating cancer | |
| ZA201408732B (en) | Composition and methods for treating wounds | |
| GB201302475D0 (en) | Compositions and methods for treating biofilms | |
| GB201302474D0 (en) | Compositions and methods for treating biofilms | |
| GB201302472D0 (en) | Compositions and methods for treating biofilms |